Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 08/29 10:00:00 pm
96.94 USD   -0.15%
08/29 NASDAQ 100 MOVE : Gild, tmus
08/22 S&P 500 MOVERS : Mro, regn
08/15 VERTEX PHARMACE : Provides Update on Ongoing Phase 3 Program for VX-..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 1 950 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals580.42100%1,032100% +77.86%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States361.0762.2%763.3273.9% +111.4%
Europe197.6134%219.6021.3% +11.13%
Other21.733.7%49.424.8% +127.45%
Managers
NameAgeSinceTitle
Jeff Leiden602009Chairman, President & Chief Executive Officer
Simon Bedson, MBA-2011SVP & GM-International Commercial Operations
Ian F. Smith492001CFO, Executive VP & Principal Financial Officer
Jeffrey A. Chodakewitz, MD602014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD512012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD641989Director
Bruce I. Sachs, MBA561998Lead Independent Director
Elaine S. Ullian681997Lead Independent Director
Margaret G. McGlynn, MBA562011Independent Director
Terrence C. Kearney, MBA612011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 247,778,698 246,058,974 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 23,247,863 9.39%
Capital Research & Management Co. (World Investors) 21,692,797 8.76%
Fidelity Management & Research Co. 21,420,752 8.65%
The Vanguard Group, Inc. 15,265,175 6.16%
Wellington Management Co. LLP 14,087,647 5.69%
BlackRock Fund Advisors 12,375,750 5.00%
SSgA Funds Management, Inc. 11,115,179 4.49%
JPMorgan Investment Management, Inc. 8,520,258 3.44%
Columbia Management Investment Advisers LLC 8,089,046 3.27%
ClearBridge Investments LLC 7,574,783 3.06%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-22.84%24 057
AMGEN, INC.5.94%128 696
GILEAD SCIENCES, INC.-21.17%105 269
CELGENE CORPORATION-9.16%84 325
REGENERON PHARMACEUTIC..-25.77%42 431
ACTELION LTD17.62%18 205
MEDIVATION INC66.22%13 332
GENMAB A/S19.24%9 905
HUALAN BIOLOGICAL ENGI..--.--%5 276
TONGHUA DONGBAO PHARMA..-83.52%4 763
TESARO INC65.25%4 441
NEUROCRINE BIOSCIENCES..-12.43%4 298
INTERCEPT PHARMACEUTIC..3.76%3 832
JUNO THERAPEUTICS INC-26.63%3 412
BEIJING SL PHARMACEUTI..--.--%3 312
CHINA BIOLOGIC PRODUCT..-21.37%3 013
KITE PHARMA INC-4.84%2 908
BIOCON LTD72.00%2 659
PEPTIDREAM INC16.39%2 607
ULTRAGENYX PHARMACEUTI..-41.61%2 583
EXELIXIS, INC.94.33%2 524
Sector Bio Therapeutic Drugs
Vertex Pharmaceuticals Inc : Connections
DataGravity, Inc.
Institute of Medicine
Museum of Science
The American Institute of Certified Public Accountants
The Boston Private Industry Council, Inc.
Institute of Chartered Accountants in England & Wales
Nantero, Inc.
The Financial Executives Institute
iControl Networks, Inc.
Biotechnology Innovation Organization
Massachusetts Life Sciences Collaborative
Infectious Diseases Society of America
Massachusetts Workforce Board Association
The American Society for Clinical Pharmacology & Therapeutics
SpiderCloud Wireless, Inc.
Vertex Pharmaceuticals
Jibo, Inc.
New England Aquarium Corp.
Massachusetts Mutual Life Insurance Co.
Massachusetts Institute of Technology
Clarus Ventures LLC
The Broad Institute, Inc.
The Alliance for Business Leadership
Whitehead Institute for Biomedical Research
WGBH Educational Foundation
American Society for Clinical Investigation
Massachusetts Life Sciences Center
Association of American Physicians
Accelerated Cure Project for Multiple Sclerosis
Alkeus Pharmaceuticals, Inc.
SimpliVity Corp.
Abington Friends School
GreatCall, Inc.
American Academy of Arts & Sciences
OneCloud Software, Inc.
Wesleyan University
Charles River Ventures, Inc.
Celebrity Series of Boston, Inc.
Biolex Therapeutics, Inc.
The Hastings Center
Macp Organization
The Brigham & Women's Hospital, Inc.
Orphan Technologies Ltd.
Harvard Medical School
New England Healthcare Institute
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem